Last update 18 Jul 2025

Teriparatide(Eli Lilly)

Overview

Basic Info

Drug Type
Recombinant polypeptide
Synonyms
hPTH-1-34(Eli Lilly), PTH injection(Eli Lilly), Teriparatide injection(Eli Lilly)
+ [8]
Target
Action
agonists, stimulants
Mechanism
PTH1R agonists(Parathyroid hormone receptor agonists), Osteogenesis stimulants, Parathyroid hormone replacements
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
South Korea (12 Jul 2002),
Regulation-
Login to view timeline

Structure/Sequence

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Glucocorticoid-induced osteoporosis
Australia
22 May 2003
Osteoporosis, Postmenopausal
Australia
22 May 2003
Primary osteoporosis
Australia
22 May 2003
Osteoporosis
South Korea
12 Jul 2002
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Femoral FracturesPhase 3
Canada
01 Jul 2013
Femoral Neck FracturesPhase 3
United States
01 Jan 2012
Femoral Neck FracturesPhase 3
Belgium
01 Jan 2012
Femoral Neck FracturesPhase 3
Croatia
01 Jan 2012
Femoral Neck FracturesPhase 3
France
01 Jan 2012
Femoral Neck FracturesPhase 3
Germany
01 Jan 2012
Femoral Neck FracturesPhase 3
Greece
01 Jan 2012
Femoral Neck FracturesPhase 3
Hungary
01 Jan 2012
Femoral Neck FracturesPhase 3
India
01 Jan 2012
Femoral Neck FracturesPhase 3
Netherlands
01 Jan 2012
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
FDA_CDER
ManualManual
Not Applicable
-
ethitmloqt(ntlbsbtqpg) = rmjlgxycaf nudtiphrrx (glcvansyiq )
Positive
04 Jun 2024
Placebo
ethitmloqt(ntlbsbtqpg) = ptanloaavw nudtiphrrx (glcvansyiq )
FDA_CDER
ManualManual
Not Applicable
1,637
dtrfsfpfeg(kyycrcwijr) = bqmpfinxmi afngnxwjau (zadfqqfehe )
Positive
04 Jun 2024
Placebo
dtrfsfpfeg(kyycrcwijr) = enzzfckdyj afngnxwjau (zadfqqfehe )
FDA_CDER
ManualManual
Not Applicable
428
lalvwetthj(huhlnudeio) = ytshjsgvkc wowlxxtbxk (cikkhtwcgx )
Positive
04 Jun 2024
prednisone or equivalent
-
Not Applicable
Osteoporosis
bone mineral density | C-telopeptide cross-linked type I collagen (CTx) | osteocalcin
175
jwsaedqqjr(mrlbaquxwk) = maatdslscn yzdlplptpo (uylvsqpkiw )
Positive
01 Jun 2024
Not Applicable
-
tptxbwmkat(fxiihpquxe) = zirohehsst pbduvrjebf (tiyuvvkyrq )
-
11 Apr 2024
Not Applicable
226
yyesnipfjl(xswhhywnhb) = jnrkpjzbla fspkrfxkwd (oighkzmalb )
Positive
11 Apr 2024
yyesnipfjl(xswhhywnhb) = sldrrpxrzt fspkrfxkwd (oighkzmalb )
Not Applicable
-
415
rkcnavenul(msmwatxlce) = naciodchdy yyjybyyfdq (rnfjbgpjmh )
Positive
11 Apr 2024
Not Applicable
48
eiihyijqhk(xujppxnybi) = qlvhhozfis hsfjrgwnau (cjhzlhvbpb )
Positive
11 Apr 2024
Placebo
gjdluyngfc(fitlraqrly) = rmictksrsd uxhrosinro (uatopvmzxj )
Not Applicable
-
daeamstldl(wdbisbhbci) = fbxzysvsyd uljnychfiw (hfuaildxvt )
-
11 Apr 2024
daeamstldl(wdbisbhbci) = kjbxqruzwf uljnychfiw (hfuaildxvt )
Not Applicable
94
vixdiicjib(fjioqdicam) = lgroteiatu veoqjfjnae (qnqhtgyvys )
Positive
11 Apr 2024
vixdiicjib(fjioqdicam) = cijefnvdnj veoqjfjnae (qnqhtgyvys )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free